Lv1
55 积分 2021-08-13 加入
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
5个月前
已完结
IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment
6个月前
已完结
The promise and challenges of immune agonist antibody development in cancer
7个月前
已完结
A new pancreatic adenocarcinoma‐derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms
9个月前
已完结
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy
9个月前
已完结
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
9个月前
已完结
APX005M, a CD40 monoclonal antibody, for patients with pancreatic adenocarcinoma
9个月前
已完结
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
10个月前
已完结
XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models
10个月前
已完结
皖公网安备34019202002308
